Summary
Cell cycle synchronization of MCF-7 hormone-sensitive human breast cancer cells has been evaluated after sequential treatment with tamoxifen and 17β-estradiol. The analysis was performed by flow cytometry. Two methods were used, one for single-parameter DNA content analysis, and one for bivariate analysis of DNA content and amount of incorporated bromodeoxyuridine (BrdUrd) into DNA using a specific monoclonal antibody. According to the BrdUrd method, tamoxifen was found (over a 30h period) to decrease (with respect to cells grown in control medium) the fraction of cells in S phase from 45% to 20%, to increase cells in G0 + G1 from 47% to 68%, and to induce a slight build-up of cells in G2 + M. Subsequent addition of estradiol resulted in partial synchronous recruitment of the cells from G0+G1 to progress through the S phase; after 6–8 h delay time, the percentage of cells in G0+G1 decreased by 50% and cells in S increased by 175%. The bivariate BrdUrd technique offered more reliable and detailed information than the single-parameter DNA analysis for differentiating and measuring the time course of estrogen-recruited cells as they progressed through early and late S phase, and has the potential for a very detailed cell kinetic analysis of bothin vitro andin vivo hormone-sensitive cells.
References
Dolbeare FA, Gratzner HG, Pallavicini MG, Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80: 5573–5577, 1983
Dolbeare F, Beisker W, Pallavicini MG, Vanderlaan M, Gray JW: Cytochemistry for bromodeoxyuridine DNA analysis: stoichiometry and sensitivity. Cytometry 6: 521–530, 1985
Soule HD, Vazquez J, Long A, Albert S, Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409–1416, 1973
Lippman M, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601, 1976
Barnes D, Sato G: Growth of a human mammary tumor cell line in a serum-free medium. Nature 281: 388–389, 1979
Edwards DP, Murthy SR, McGuire WL: Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer. Cancer Res 40: 1722–1726, 1980
Butler WB, Kelsey WH, Goran N: Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens. Cancer Res 41: 82–88, 1981
Sutherland RL, Hall RE, Taylor IW: Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 43: 3998–4006, 1983
Briand P, Lykkesfeldt AE: Effect of estrogen and antiestrogen on the human breast cancer cell line, MCF-7 adapted to growth at low serum concentration. Cancer Res 44: 1114–1119, 1984
Osborne CK, Boldt DH, Estrada P: Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res 44: 1433–1439, 1984
Papendorf JT, Schatz RW, Soto AM, Sonnenschein C: On the role of 17 alpha-estradiol and 17 beta-estradiol in the proliferation of MCF-7 and T47D-A11 human breast tumor cells. J Cell Phys 125: 591–595, 1985
Lykkesfeldt AE, Briand P: Indirect mechanism of estradiol stimulation of cell proliferation of human breast cancer cell lines. Br J Cancer 53: 29–35, 1986
Briand P, Lykkesfeldt AE: Long-term cultivation of a human breast cancer cell line, MCF-7, in a chemically defined medium. Effect of estradiol. Anticancer Res 6: 85–90, 1986
Osborne CK, Boldt DH, Clark GM, Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43: 3583–3585, 1983
Lykkesfeldt AE, Larsen JK, Christensen IJ, Briand P: Effects of the antiestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer 49: 717–722, 1984
Taylor IW, Hodson PJ, Green MD, Sutherland RL: Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res 43: 4007–4010, 1983
Thornthwaite JT, Sugarbaker EV, Temple WJ: Preparation of tissue for DNA flow cytometric analysis. Cytometry 1: 229–237, 1980
Dean PN, Jett JH: Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 60: 523–527, 1974
Lippman M: Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three? Breast Cancer Res Treat 3: 117–127, 1983
Lippman M, Cassidy J, Wesley M, Young R: A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization. Proc Am Soc Clin Oncol 1: 317, 1982
Esber HJ, Payne IJ, Bogden AE: Variability of hormone concentrations and ratios in commercial sera used for tissue culture. J Natl Cancer Inst 50: 559–562, 1973
Bruenner N, Bronzert D, Vindeløv LL, Spang-Thomsen M, Lippman ME: Effect on growth and cell cycle kinetics of tamoxifen and estradiol on MCF-7 human breast cancer cells grownin vitro and in nude mice. Proc Am Assoc Cancer Res 28: 931, 1987
Redman B, Chou TH: Effect of tamoxifen on MCF-7 cell line grown with commercial untreated serum. Proc Am Assoc Cancer Res 28: 932, 1987
Lykkesfeldt AE, Larsen JK, Christensen IJ: Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7. Breast Cancer Res Treat 7 (Suppl): 83–90, 1986
Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh J: Subpopulations of MCF-7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci USA 84: 7295–7299, 1987
Begg AC, McNally NJ, Shrieve DC, Kaercher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620–626, 1985
Sasaki K, Murakami T, Ogino T, Takahashi M, Kawasaki S: Flow cytometric estimation of cell cycle parameters using a monoclonal antibody to bromodeoxyuridine. Cytometry 7: 391–395, 1986
Sasaki K, Murakami T, Takahashi M: A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine. Cytometry 8: 526–528, 1987
Wilson GD, McNally NJ, Dunphy E, Kaercher H, Pfragner R: The labelling index of human and mouse tumours assessed by bromodeoxyuridine stainingin vitro andin vivo and flow cytometry. Cytometry 6: 641–647, 1985
Danova M, Wilson G, Riccardi A, Mazzini G, Ucci G, Giordano M, Brugnatelli S, Luoni R, McNally NJ, Ascari E:In vivo administration of bromodeoxyuridine and flow cytometry for cell kinetic studies in human malignancies. Haematologica 72: 115–119, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bruno, S., Di Vinci, A., Geido, E. et al. Cell cycle synchronization induced by tamoxifen and 17β-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine. Breast Cancer Res Tr 11, 221–229 (1988). https://doi.org/10.1007/BF01807280
Issue Date:
DOI: https://doi.org/10.1007/BF01807280